
Opioid Agonist Therapy (OAT) for opioid dependency Abstract. The process of evaluating the necessity of an Opioid Agonist Therapy (OAT) is relatively simple. Once the criteria for an opioid dependency according to the ICD-10 (or DSM V) are met, treatment should be offered. Adequate individual dosing of the opioid agonist is crucial to treatment success. Several equally effective opioids are available. Comorbidities are common and should be taken into account when planning and conducting an OAT. In this article the State-Of-The-Art of the OAT will be presented, focusing upon the German-speaking European countries. The article provides an overview of diagnosis, treatment modalities, drug therapy and some specific challenges of the OAT. Treatment recommendations are in accordance with the Swiss model, hence adaptations to treatment due to local state laws may be necessary in other countries.
Analgesics, Opioid, Europe, Opiate Substitution Treatment, Humans, Opioid-Related Disorders, Methadone, Buprenorphine
Analgesics, Opioid, Europe, Opiate Substitution Treatment, Humans, Opioid-Related Disorders, Methadone, Buprenorphine
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
